These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12377648)

  • 1. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers.
    Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
    Ann Oncol; 2002 Oct; 13(10):1598-604. PubMed ID: 12377648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.
    Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
    Ann Oncol; 2002 Oct; 13(10):1605-11. PubMed ID: 12377649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
    Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T
    Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.
    Khatun S; Fujimoto J; Toyoki H; Tamaya T
    Cancer Sci; 2003 Sep; 94(9):769-73. PubMed ID: 12967474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
    Xu FL; Li YL; Wang ZD; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):396-400. PubMed ID: 12974081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle.
    Fujimoto J; Aoki I; Toyoki H; Khatun S; Sato E; Tamaya T
    J Biomed Sci; 2003; 10(3):320-7. PubMed ID: 12711859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
    Fujimoto J; Aoki I; Toyoki H; Khatun S; Sato E; Sakaguchi H; Tamaya T
    Oncology; 2004; 66(5):420-8. PubMed ID: 15331930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.
    Fujimoto J; Toyoki H; Sato E; Sakaguchi H; Jahan I; Alam SM; Tamaya T
    J Biomed Sci; 2006 Nov; 13(6):825-32. PubMed ID: 17013750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Br J Cancer; 1999 May; 80(5-6):827-33. PubMed ID: 10360662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
    Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
    Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
    Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
    Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
    Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different angiogenic pathways in human cervical cancers.
    Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
    Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.
    Tomita N; Morishita R; Taniyama Y; Koike H; Aoki M; Shimizu H; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Circulation; 2003 Mar; 107(10):1411-7. PubMed ID: 12642363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers.
    Toyoki H; Fujimoto J; Sato E; Sakaguchi H; Tamaya T
    Ann Oncol; 2005 Jan; 16(1):51-5. PubMed ID: 15598938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of IP-10 related to angiogenesis in uterine cervical cancers.
    Sato E; Fujimoto J; Toyoki H; Sakaguchi H; Alam SM; Jahan I; Tamaya T
    Br J Cancer; 2007 Jun; 96(11):1735-9. PubMed ID: 17505511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.